Galderma’s $1.5 Billion Skincare Deal. Somebody Please Show Me the Synergy Spreadsheet.
Strategic fit can be compelling. I’d still trace Galderma’s ZO deal through the purchase price, financing and the people expected to deliver the synergies.
Strategic fit can be compelling. I’d still trace Galderma’s ZO deal through the purchase price, financing and the people expected to deliver the synergies.
A $700,000 CFO signing bonus can be rational. I’d compare the premium with the cost of waiting, interim leadership and the capability the company needs.
Deloitte finds 90% of CFOs more optimistic about their companies while 83% view U.S. stocks as overvalued. Sarah Schlott explains what that means for 2027 capital allocation.
Is one customer too much of your revenue? Learn to calculate customer concentration risk and stress-test its impact on profit and cash flow.
FP&A consulting, forecasting, accounting support and finance strategy for CFOs and growing finance teams.